MCID: HYP074
MIFTS: 48

Hypersensitivity Vasculitis malady

Categories: Rare diseases, Cardiovascular diseases, Bone diseases, Immune diseases

Aliases & Classifications for Hypersensitivity Vasculitis

Aliases & Descriptions for Hypersensitivity Vasculitis:

Name: Hypersensitivity Vasculitis 12 50 14
Cutaneous Small Vessel Vasculitis 50 56 69
Vasculitis, Leukocytoclastic, Cutaneous 42 69
Cutaneous Leukocytoclastic Vasculitis 50 56
Cutaneous Leukocytoclastic Angiitis 50 56
Hypersensitivity Angiitis 50 56
Cutaneous Hypersensitivity Vasculitis 56
Drug Induced Cutaneous Vasculitis 69
Leukocytoclastic Vasculitis 69
Leukocytoclastic Angiitis 50

Characteristics:

Orphanet epidemiological data:

56
cutaneous leukocytoclastic angiitis
Inheritance: Not applicable; Age of onset: All ages;

Classifications:



External Ids:

Disease Ontology 12 DOID:9809
ICD10 33 D69.0 M31.0
ICD9CM 35 446.2 446.20
MeSH 42 D018366
NCIt 47 C35119
Orphanet 56 ORPHA889
ICD10 via Orphanet 34 M31.0
UMLS 69 C0151436

Summaries for Hypersensitivity Vasculitis

NIH Rare Diseases : 50 hypersensitivity vasculitis is an extreme reaction to a drug, infection, or foreign substance that leads to inflammation and damage to blood vessels of the skin. signs and symptoms may include purple-colored spots and patches on the skin; skin lesions on the legs, buttocks, or trunk; blisters on the skin; hives (urticaria); and/or open sores with dead tissue (necrotic ulcers). this condition is caused by an allergic reaction to a drug or other foreign substance. this condition usually goes away over time; but on occasion, people can have repeated episodes. last updated: 12/14/2011

MalaCards based summary : Hypersensitivity Vasculitis, also known as cutaneous small vessel vasculitis, is related to allergic cutaneous vasculitis and vasculitis, and has symptoms including arthralgia, myalgia and fever. An important gene associated with Hypersensitivity Vasculitis is CRP (C-Reactive Protein), and among its related pathways/superpathways are Innate Immune System and Allograft rejection. The drugs Cyclosporine and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and liver, and related phenotype is immune system.

Wikipedia : 71 Cutaneous small-vessel vasculitis (also known as \"Cutaneous leukocytoclastic angiitis\", \"Cutaneous... more...

Related Diseases for Hypersensitivity Vasculitis

Diseases related to Hypersensitivity Vasculitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)
id Related Disease Score Top Affiliating Genes
1 allergic cutaneous vasculitis 10.9
2 vasculitis 10.5
3 fallopian tube adenomatoid tumor 10.3 CRP MPO
4 alcoholic neuropathy 10.3 CD40LG CD79A
5 camptodactyly vertebral fusion 10.3 CD40LG CD79A
6 spinal polio 10.3 CD40LG CD79A
7 rabies 10.3 CD40LG CD79A
8 unilateral retinoblastoma 10.3 CD40LG CD79A
9 mesangial proliferative glomerulonephritis 10.3 CD40LG CD79A
10 delta chain disease 10.3 CD40LG CD79A
11 discitis 10.3 CD40LG CD79A
12 spinal canal and spinal cord meningioma 10.3 CD40LG CD79A
13 parapharyngeal meningioma 10.3 CRP MPO
14 trichostrongyloidiasis 10.3 CD40LG CD79A
15 colloid adenoma 10.3 CD40LG CD79A
16 vulvar disease 10.3 CD79A MPO
17 heart septal defect 10.3 CD40LG CD79A
18 cutaneous polyarteritis nodosa 10.3 CD40LG CD79A
19 mild pre-eclampsia 10.3 CD40LG CD79A
20 retinal microaneurysm 10.3 CD40LG CD79A
21 retinal cancer 10.3 CRP MEFV
22 tonsil cancer 10.3 CD40LG CD79A
23 polycythemia due to hypoxia 10.3 CD40LG CRP
24 indomethacin antenatal infection 10.3 CD40LG CD79A
25 postcricoid region cancer 10.3 CD40LG CD79A
26 beach ear 10.3 CD40LG CD79A
27 acute kidney tubular necrosis 10.3 CD40LG CD79A
28 atheroembolism of kidney 10.3 CD40LG CD79A
29 partial sensory epilepsy 10.3 CD40LG CD79A
30 ritscher-schinzel syndrome 1 10.3 CD40LG CD79A
31 diabetic angiopathy 10.3 CD40LG CD79A
32 jaw cancer 10.3 CD40LG MPO
33 endocarditis 10.3 CD40LG CD79A
34 muscular dystrophy 10.3 CD40LG CD79A
35 dumping syndrome 10.3 CD40LG CD79A
36 striatonigral degeneration 10.3 CD40LG CD79A
37 ciliary body spindle cell melanoma 10.3 CD40LG CD79A
38 purulent endophthalmitis 10.3 CD40LG CD79A
39 acro coxo mesomelic dysplasia 10.3 C3 CRP
40 mu chain disease 10.3 CD40LG CD79A
41 generalized atherosclerosis 10.3 CD40LG CD79A
42 bursitis 10.3 CD40LG CD79A
43 syphilis 10.3 CD40LG CD79A
44 nerve compression syndrome 10.3 CD40LG MPO
45 homocystinuria 10.3 CD40LG CD79A
46 mental retardation, autosomal dominant 19 10.2 CD40LG CD79A
47 hemangioma of orbit 10.2 CD40LG CD79A
48 eosinophilic fasciitis 10.2 CD79A MPO
49 immunoglobulin beta deficiency 10.2 CD40LG CD79A
50 gestational diabetes 10.2 CD40LG CD79A

Comorbidity relations with Hypersensitivity Vasculitis via Phenotypic Disease Network (PDN):


Acute Cystitis Deficiency Anemia
Heart Disease Postinflammatory Pulmonary Fibrosis
Rheumatoid Arthritis Systemic Lupus Erythematosus

Graphical network of the top 20 diseases related to Hypersensitivity Vasculitis:



Diseases related to Hypersensitivity Vasculitis

Symptoms & Phenotypes for Hypersensitivity Vasculitis

Human phenotypes related to Hypersensitivity Vasculitis:

56 32 (show all 14)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 arthralgia 56 32 Frequent (79-30%) HP:0002829
2 myalgia 56 32 Very frequent (99-80%) HP:0003326
3 fever 56 32 Very frequent (99-80%) HP:0001945
4 subcutaneous nodule 56 32 Occasional (29-5%) HP:0001482
5 purpura 56 32 Very frequent (99-80%) HP:0000979
6 erythema 56 32 Very frequent (99-80%) HP:0010783
7 skin rash 56 32 Frequent (79-30%) HP:0000988
8 urticaria 56 32 Very frequent (99-80%) HP:0001025
9 vasculitis 56 32 Very frequent (99-80%) HP:0002633
10 papule 56 32 Very frequent (99-80%) HP:0200034
11 gangrene 56 32 Very frequent (99-80%) HP:0100758
12 cutis marmorata 56 32 Very frequent (99-80%) HP:0000965
13 recurrent skin infections 56 32 Very frequent (99-80%) HP:0001581
14 abnormality of the oral cavity 56 32 Occasional (29-5%) HP:0000163

MGI Mouse Phenotypes related to Hypersensitivity Vasculitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.23 C1GALT1 C3 CD40LG CD79A CRP HSP90AA1

Drugs & Therapeutics for Hypersensitivity Vasculitis

Drugs for Hypersensitivity Vasculitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 113)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclosporine Approved, Investigational, Vet_approved Phase 4 79217-60-0, 59865-13-3 5284373 6435893
2
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
3
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
5
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3 53-03-2 5865
6
Dapsone Approved, Investigational Phase 4,Phase 2 80-08-0 2955
7
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-05-9 54575, 6560146 143
8
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037
9 Prednisolone acetate Phase 4,Phase 2,Phase 3
10 glucocorticoids Phase 4,Phase 2,Phase 3
11 Gastrointestinal Agents Phase 4,Phase 2,Phase 3
12 Neuroprotective Agents Phase 4,Phase 2,Phase 3
13 Dermatologic Agents Phase 4,Phase 3,Phase 2
14 Hormone Antagonists Phase 4,Phase 2,Phase 3
15 Hormones Phase 4,Phase 2,Phase 3
16 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3
17 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3
18 Prednisolone hemisuccinate Phase 4,Phase 2,Phase 3
19 Prednisolone phosphate Phase 4,Phase 2,Phase 3
20 Anti-Infective Agents Phase 4,Phase 2
21 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1
22 Protective Agents Phase 4,Phase 2,Phase 3
23 Antiemetics Phase 4,Phase 2,Phase 3
24 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3
25 Antifungal Agents Phase 4
26 Methylprednisolone acetate Phase 4,Phase 2,Phase 3
27 Methylprednisolone Hemisuccinate Phase 4,Phase 2,Phase 3
28 Antirheumatic Agents Phase 4,Phase 2,Phase 3,Phase 1
29 Autonomic Agents Phase 4,Phase 2,Phase 3
30 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3
31 Calcineurin Inhibitors Phase 4
32 Folic Acid Antagonists Phase 4,Phase 3,Phase 2
33 Vaccines Phase 4
34 Vitamin B Complex Phase 4,Phase 3,Phase 2
35 Anti-Bacterial Agents Phase 4,Phase 2,Phase 1
36 Antimalarials Phase 4,Phase 2
37 Antiparasitic Agents Phase 4,Phase 2
38 Antiprotozoal Agents Phase 4,Phase 2
39 Tetrahydrozoline Phase 4
40 Ophthalmic Solutions Phase 4
41 Folate Nutraceutical Phase 4,Phase 3,Phase 2
42 Vitamin B9 Nutraceutical Phase 4,Phase 3,Phase 2
43 Omega 3 Fatty Acid Nutraceutical Phase 4
44
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
45
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
46
Azathioprine Approved Phase 2, Phase 3 446-86-6 2265
47
Etanercept Approved, Investigational Phase 3,Phase 2 185243-69-0
48
rituximab Approved Phase 2, Phase 3,Phase 1 174722-31-7 10201696
49
Infliximab Approved Phase 3 170277-31-3
50 Alkylating Agents Phase 2, Phase 3

Interventional clinical trials:

(show top 50) (show all 65)
id Name Status NCT ID Phase
1 Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Completed NCT01985997 Phase 4
2 HSP-glomerulonephritis Trial: MP vs CyA Completed NCT00425724 Phase 4
3 Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Recruiting NCT02550080 Phase 4
4 Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels Terminated NCT00578578 Phase 4
5 Cacicol20® in Corneal Wound Healing and Nerve Regeneration After Phototherapeutic Keratectomy Terminated NCT02373397 Phase 4
6 Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Completed NCT00104299 Phase 2, Phase 3
7 A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis Completed NCT02020889 Phase 3
8 Etanercept Treatment in the Early Course of Polymyalgia Rheumatica Completed NCT00524381 Phase 3
9 Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders Completed NCT00157079 Phase 3
10 KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) Recruiting NCT03065244 Phase 3
11 An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) Active, not recruiting NCT01791153 Phase 3
12 Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura Unknown status NCT01104428 Phase 2
13 Steroids and Methotrexate to Treat Systemic Vasculitis Completed NCT00001256 Phase 2
14 Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes Completed NCT00004567 Phase 2
15 Etanercept to Treat Wegener's Granulomatosis Completed NCT00001901 Phase 2
16 Treatment of Wegener's Granulomatosis With Cyclophosphamide Completed NCT00001155 Phase 2
17 Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis Completed NCT00029107 Phase 2
18 Absorption of Corticosteroids in Children With Juvenile Dermatomyositis Completed NCT00004357 Phase 2
19 Daclizumab to Treat Wegener's Granulomatosis Completed NCT00040248 Phase 2
20 Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses Completed NCT01170936 Phase 2
21 Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Completed NCT00266565 Phase 1, Phase 2
22 A Randomized Multicenter Study for Isolated Skin Vasculitis Recruiting NCT02939573 Phase 2
23 Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities Recruiting NCT01431105 Phase 1, Phase 2
24 The Research of Standard Diagnosis and Treatment for Severe HSP in Children Recruiting NCT02540720 Phase 2
25 The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children Recruiting NCT02532790 Phase 2
26 The Research of Standard Diagnosis and Treatment for HSPN in Children Recruiting NCT02532777 Phase 2
27 A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Active, not recruiting NCT01750697 Phase 2
28 Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease Withdrawn NCT00305201 Phase 2
29 Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions Completed NCT00001764 Phase 1
30 Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis Completed NCT00001761 Phase 1
31 An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies Completed NCT00072592 Phase 1
32 Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases Unknown status NCT00006055
33 Positron Emission Tomography of Infection and Vasculitis Unknown status NCT01878721
34 Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation Unknown status NCT02180126
35 Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized Patients Unknown status NCT01238003
36 Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis Unknown status NCT00361192 Early Phase 1
37 Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura Unknown status NCT01610830
38 Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides Completed NCT00001473
39 Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis Completed NCT00001541
40 Pending Failure in Hard-hard Total Hip Arthroplasty Completed NCT02427984
41 Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus Completed NCT00730002
42 Educational Needs of Patients With Systemic Vasculitis Completed NCT02190929
43 Impact of Vasculitis on Employment and Income Completed NCT02476292
44 Vasculitis Illness Perception (VIP) Study Completed NCT02190916
45 Reproductive Health in Men and Women With Vasculitis Completed NCT02176070
46 Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography Completed NCT00001759
47 Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura Completed NCT00190229
48 Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL) Completed NCT00974883
49 Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN Completed NCT00301613
50 IgA-positive Versus IgA-negative Immune Complex Vasculitis Recruiting NCT01815190

Search NIH Clinical Center for Hypersensitivity Vasculitis

Cochrane evidence based reviews: vasculitis, leukocytoclastic, cutaneous

Genetic Tests for Hypersensitivity Vasculitis

Anatomical Context for Hypersensitivity Vasculitis

MalaCards organs/tissues related to Hypersensitivity Vasculitis:

39
Skin, Bone, Liver, Breast, Thyroid

Publications for Hypersensitivity Vasculitis

Articles related to Hypersensitivity Vasculitis:

(show top 50) (show all 70)
id Title Authors Year
1
Revisiting clinical differences between hypersensitivity vasculitis and Henoch-SchAPnlein purpura in adults from a defined population. ( 24528895 )
2014
2
Paracetamol-induced hypersensitivity vasculitis in a 10-year-old child. ( 24379075 )
2013
3
Carbimazole-associated hypersensitivity vasculitis in a cat. ( 24255992 )
2013
4
Ink sick: tattoo ink hypersensitivity vasculitis. ( 21035978 )
2011
5
Hypersensitivity vasculitis associated with leuprolide (Lupron). ( 20470239 )
2010
6
Hepatitis C- and human immunodeficiency virus-induced hypersensitivity vasculitis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. ( 19921341 )
2010
7
A stinging rash of indeterminate origin. Idiopathic hypersensitivity vasculitis. ( 19235501 )
2009
8
Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor. ( 20204065 )
2009
9
Immunological diagnosis of cutaneous-pulmonary hypersensitivity vasculitis. ( 17332983 )
2007
10
A case of hypersensitivity vasculitis after vinorelbine injection in a patient with metastatic breast cancer. ( 17419038 )
2007
11
Renal hypersensitivity vasculitis associated with dapsone. ( 16183407 )
2005
12
Prevalence of human parvovirus B19 component NS1 gene in patients with Henoch-Schonlein purpura and hypersensitivity vasculitis. ( 15888184 )
2005
13
Hypersensitivity vasculitis induced by cefoperazone/sulbactam. ( 12556245 )
2003
14
Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis. ( 12700924 )
2003
15
Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. ( 12702983 )
2003
16
Hypersensitivity vasculitis and cytokines. ( 12426663 )
2002
17
Hypersensitivity vasculitis induced by cefprozil. ( 17159422 )
2002
18
Hypersensitivity vasculitis in adults: a benign disease usually limited to skin. ( 11247332 )
2001
19
Are Henoch-SchAPnlein purpura and hypersensitivity vasculitis in adults truly distinct entities? A dermatologist's perspective. ( 11138325 )
2000
20
Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-SchAPnlein purpura in adults. ( 10406408 )
1999
21
Amyloid goiter presented as a subacute thyroiditis-like symptom in a patient with hypersensitivity vasculitis. ( 9790279 )
1998
22
Hypersensitivity vasculitis (microscopic polyangiitis) in pregnancy with transmission to the neonate. ( 9746391 )
1998
23
Gastrointestinal amyloidosis secondary to hypersensitivity vasculitis presenting with intestinal pseudoobstruction. ( 9724175 )
1998
24
Hypersensitivity vasculitis related to aceclofenac. ( 9159552 )
1997
25
Severe cutaneous thrombotic hypersensitivity vasculitis. ( 9385997 )
1997
26
Hypersensitivity vasculitis--not always benign? ( 9251631 )
1997
27
Bilateral leg pain and bruising. Hypersensitivity vasculitis. ( 9305435 )
1997
28
Hypersensitivity vasculitis. ( 9329546 )
1997
29
Clinical features and outcome of 95 patients with hypersensitivity vasculitis. ( 9217569 )
1997
30
Nonsteroidal antiinflammatory drug induced hypersensitivity vasculitis clinically mimicking temporal arteritis. ( 8838531 )
1996
31
Case report: ofloxacin-induced hypersensitivity vasculitis. ( 8615379 )
1996
32
Idiopathic hypersensitivity vasculitis: clinicopathologic correlation of 61 cases. ( 8543412 )
1995
33
Therapy of resistant systemic necrotizing vasculitis. Polyarteritis, Churg-Strauss syndrome, Wegener's granulomatosis, and hypersensitivity vasculitis group disorders. ( 7732173 )
1995
34
Hypersensitivity vasculitis of the duodenum. ( 8092020 )
1994
35
Hypersensitivity vasculitis associated with piperazine therapy. ( 8043407 )
1994
36
Ciprofloxacin-induced hypersensitivity vasculitis. ( 7941927 )
1994
37
Ciprofloxacin induced hypersensitivity vasculitis syndrome. ( 8262601 )
1993
38
Acute hantavirus infection presenting as hypersensitivity vasculitis with arthropathy. ( 8095959 )
1993
39
Hypersensitivity vasculitis and Henoch-SchAPnlein purpura: a comparison between the 2 disorders. ( 8350321 )
1993
40
Hypersensitivity vasculitis related to nicoumalone. ( 8490477 )
1993
41
Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants. ( 8422654 )
1993
42
Elimination diet in the treatment of selected patients with hypersensitivity vasculitis. ( 1505105 )
1992
43
Systemic hypersensitivity vasculitis associated with bronchiectasis. ( 1386569 )
1992
44
Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. ( 1424898 )
1992
45
Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. ( 1555358 )
1992
46
Hypersensitivity vasculitis and Henoch-SchAPnlein purpura: a comparison between the 2 disorders. ( 1613701 )
1992
47
Cutaneous vasculitis, hypersensitivity vasculitis, erythema nodosum, and pyoderma gangrenosum. ( 2043448 )
1991
48
Hypersensitivity vasculitis occurring in a patient receiving immunotherapy. ( 1826508 )
1991
49
Cutaneous vasculitis, hypersensitivity vasculitis, erythema nodosum, and pyoderma gangrenosum. ( 2223458 )
1990
50
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. ( 2202309 )
1990

Variations for Hypersensitivity Vasculitis

Expression for Hypersensitivity Vasculitis

Search GEO for disease gene expression data for Hypersensitivity Vasculitis.

Pathways for Hypersensitivity Vasculitis

GO Terms for Hypersensitivity Vasculitis

Biological processes related to Hypersensitivity Vasculitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 9.46 C3 C4A CD79A MEFV
2 B cell proliferation GO:0042100 9.26 CD40LG CD79A
3 inflammatory response GO:0006954 9.02 C3 C4A CD40LG CRP MEFV
4 positive regulation of apoptotic cell clearance GO:2000427 8.96 C3 C4A

Molecular functions related to Hypersensitivity Vasculitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 endopeptidase inhibitor activity GO:0004866 8.96 C3 C4A
2 complement component C1q binding GO:0001849 8.62 C4A CRP

Sources for Hypersensitivity Vasculitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....